N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: Glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population

Mark A Babizhayev1, Leslie Burke2, Philip Micans3, Stuart P Richer4,51Innovative Vision Products, Inc., County of New Castle, Delaware, USA; 2Wise Choice Products LLC, London, England, United Kingdom; 3IAS Group, Sark, United Kingdom; 4Eye Clinic DVA Medical Center, North Chicago, Illinois, USA; 5De...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mark A Babizhayev, Leslie Burke, Philip Micans, Stuart P Richer
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	age-related ophthalmic diseases cataract disability-glare halos Halometer visual-acuity N-acetylcarnosine lubricant eye drops repurchase behavior analysis 50000-patients’ compliance to self-administer eye drops Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/6efa6d7812914e16a005c86b5b78bb27
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: Glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population

Ejemplares similares